Rituximab in the Treatment of Refractory Myasthenia Gravis : Studying the Outcomes using MMT Score and Need for Plasmapheresis in Baghdad Teaching Hospital . Indian Journal of Forensic Medicine & Toxicology, [S. l.], v. 14, n. 2, p. 1400–1405, 2020. DOI: 10.37506/ijfmt.v14i2.3108. Disponível em: https://medicopublication.com/index.php/ijfmt/article/view/3108. Acesso em: 4 jun. 2026.